- The EIB granted MedinCell a 40M€ credit facility in November 2022, fully drawn since July 2023 after completion of all conditions specified in the agreement
- MedinCell and EIB agreed that one financial covenant of the agreement no longer fits for the Company and therefore decided to replace it with a covenant more suitable to the Company business model, effective since September 28, 2023